These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 23382487)

  • 1. Blood pressure variability in elderly persons with white-coat and masked hypertension compared to those with normotension and sustained hypertension.
    Cacciolati C; Tzourio C; Hanon O
    Am J Hypertens; 2013 Mar; 26(3):367-72. PubMed ID: 23382487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.
    Gijón-Conde T; Graciani A; López-García E; Guallar-Castillón P; García-Esquinas E; Rodríguez-Artalejo F; Banegas JR
    Hypertens Res; 2017 Jun; 40(6):613-619. PubMed ID: 28179625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Johansson J; Jula AM
    J Hypertens; 2012 Apr; 30(4):705-12. PubMed ID: 22278146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent retinal vascular abnormalities in normotensive persons and patients with never-treated, masked, white coat hypertension.
    Triantafyllou A; Doumas M; Anyfanti P; Gkaliagkousi E; Zabulis X; Petidis K; Gavriilaki E; Karamaounas P; Gkolias V; Pyrpasopoulou A; Haidich AB; Zamboulis C; Douma S
    Am J Hypertens; 2013 Mar; 26(3):318-25. PubMed ID: 23382481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension.
    Afsar B
    J Cardiol; 2013 Mar; 61(3):222-6. PubMed ID: 23294898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure and heart rate variability and baroreflex sensitivity in white-coat, masked, and sustained hypertension.
    Sheng CS; Li FK; Cheng YB; Wei FF; Huang JF; Guo QH; Zhang DY; Wang Y; An DW; Huang QF; Li Y; Wang JG
    Hypertens Res; 2020 Aug; 43(8):772-780. PubMed ID: 32051566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2012 Mar; 25(3):297-305. PubMed ID: 22089106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
    Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of blood pressure variability during office visit on the estimation of blood pressure control in treated hypertensive patients].
    Villeneuve F; Rosenbaum D; Gury C; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):198-202. PubMed ID: 22677179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.
    Stergiou GS; Asayama K; Thijs L; Kollias A; Niiranen TJ; Hozawa A; Boggia J; Johansson JK; Ohkubo T; Tsuji I; Jula AM; Imai Y; Staessen JA;
    Hypertension; 2014 Apr; 63(4):675-82. PubMed ID: 24420553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study.
    Satoh M; Asayama K; Kikuya M; Inoue R; Metoki H; Hosaka M; Tsubota-Utsugi M; Obara T; Ishiguro A; Murakami K; Matsuda A; Yasui D; Murakami T; Mano N; Imai Y; Ohkubo T
    Hypertension; 2016 Jan; 67(1):48-55. PubMed ID: 26527046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension.
    Kushiro T; Kario K; Saito I; Teramukai S; Mori Y; Okuda Y; Shimada K
    Hypertens Res; 2015 Mar; 38(3):178-85. PubMed ID: 25354777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension.
    Kang YY; Li Y; Huang QF; Song J; Shan XL; Dou Y; Xu XJ; Chen SH; Wang JG
    J Hypertens; 2015 Aug; 33(8):1580-7. PubMed ID: 26103131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
    Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
    Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target organ damage and masked hypertension in the general population: the Finn-Home study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Kesäniemi YA; Kähönen M; Jula AM
    J Hypertens; 2013 Jun; 31(6):1136-43. PubMed ID: 23466942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
    Wojciechowska W; Stolarz-Skrzypek K; Olszanecka A; Klima Ł; Gąsowski J; Grodzicki T; Kawecka-Jaszcz K; Czarnecka D
    Blood Press; 2016 Aug; 25(4):249-56. PubMed ID: 26953075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study.
    Ugajin T; Hozawa A; Ohkubo T; Asayama K; Kikuya M; Obara T; Metoki H; Hoshi H; Hashimoto J; Totsune K; Satoh H; Tsuji I; Imai Y
    Arch Intern Med; 2005 Jul; 165(13):1541-6. PubMed ID: 16009871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.
    Sivén SS; Niiranen TJ; Kantola IM; Jula AM
    J Hypertens; 2016 Jan; 34(1):54-60. PubMed ID: 26630213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian variation of blood pressure and heart rate in normotensives, white-coat, masked, treated and untreated hypertensives.
    Koroboki E; Manios E; Psaltopoulou T; Vemmos K; Michas F; Alexaki E; Zakopoulos N
    Hellenic J Cardiol; 2012; 53(6):432-8. PubMed ID: 23178426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.